HC Wainwright Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $11.00
Vera Therapeutics (NASDAQ:VERA – Get Rating) had its price objective cut by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Wednesday, The Fly reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Vera Therapeutics’ Q1 2023 earnings at ($0.70) EPS, Q2 2023 […]